Asset Management

Here’s why Pfizer’s vaccine bombshell may kick off a ‘massive rotation’ to value stocks

The news of a Covid-19 vaccine could spur investors to pile back into so-called value stocks

Here’s why Pfizer’s vaccine bombshell may kick off a ‘massive rotation’ to value stocks
Photo: Matteo Rossetti//Getty Images

Some of the world's largest investors had already started to pile into some of the world's most unloved stocks in anticipation that a vaccine would help lift share prices.

News of a promising trial of a vaccine against Covid-19 is what value investors have been waiting for.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump